Egon Michael Haberfellner

Paracelsus Medical University Salzburg, Salzburg, Salzburg, Austria

Are you Egon Michael Haberfellner?

Claim your profile

Publications (31)36.2 Total impact

  • Egon Michael Haberfellner
    Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater 02/2009; 23(1):1-3. · 1.38 Impact Factor
  • Egon Michael Haberfellner, Sabine Zankl
    [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung HINTERGRUND. Unter oberösterreichischen Psychotherapeuten wurde eine Befragung durchgeführt, um deren Einstellungen zum Thema "sexuelle Kontakte in der Psychotherapie" zu erheben. METHODE. 204 Psychotherapeuten beteiligten sich an der Befragung. ERGEBNISSE. 2,5 % der befragten Psychotherapeuten waren der Ansicht, dass sexuelle Aktivitäten eine hilfreiche Intervention sein können. 22 % waren nicht informiert, dass sexueller Kontakt mit Patienten strafrechtlich verfolgt werden kann. 60 % vertraten die Meinung, dass sexuelle Kontakte nach Abschluss einer Psychotherapie unter bestimmten Umständen vertretbar sind. DISKUSSION. Nur von einzelnen Psychotherapeuten wurden eindeutig unethische Positionen vertreten. Viele Psychotherapeuten sind sich nicht darüber im Klaren, dass sexuelle Kontakte auch nach Abschluss einer Psychotherapie ethisch zu verurteilen sind. Diskussionen und Fortbildungen über diese Thematik sind dringend notwendig.
    Psychotherapie Forum 08/2008; 16(2):92-97.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Medical rehabilitation of patients with mental disorders is new in Austria. A catamnestic study was performed to evaluate the effects of an inpatient treatment programme. 355 patients were included in the study in 2003, 262 patients (73.8%) were evaluated after one year. The sample included patients with "severe mental illness" (about 25%) as well as patients with neurotic disorders. Patients' symptoms and quality of life had improved. The effect sizes admission-dismissal were between 0.17 and 0.62, the effect sizes after one year were between 0.10 and 0.25. Duration of sick leave was 20.5 weeks in the year before rehabilitation and 6.5 weeks in the year after rehabilitation. Duration of hospitalization was three weeks before versus 1.5 weeks after rehabilitation. Patients who had been employed at admission had a good chance to remain on the job (65.8%). Disease-related factors did not predict treatment outcome. A medical rehabilitation concept showed positive therapy outcomes for patients with severe mental illness as well as for patients with neurotic disorders.
    Die Rehabilitation 07/2008; 47(3):164-71. · 0.71 Impact Factor
  • Egon Michael Haberfellner
    Psychiatrie und Psychotherapie 06/2008; 4(2):66-68.
  • Egon Michael Haberfellner
    [Show abstract] [Hide abstract]
    ABSTRACT: In Austria vehicle drivers impaired by drugs or alcohol have to undergo a psychiatric examination. Drivers who are not accused for impaired driving have to undergo a psychiatric examination too if they are suspected to be alcohol - or drug addicted. Public health officers decide on the need to refer to psychiatric examination. 145 drivers suspected to be alcohol - or drug addicted had been referred to the author for psychiatric examination between January 2002 and August 2005. The records of these patients were examined for the following criteria: the reason for psychiatric examination (accident, impaired driving, others), the pattern of substance using, abnormal laboratory testing (urine test, lever function test, carbohydrate-deficient transferrin). Alcohol consumers/abusers and drug consumers/abusers were compared. Alcohol consumers/ abusers (n=75) had regularly been penalized for impaired driving (86.7%) or for accidents (26.7%) and 88% had consumed alcohol regularly (once a week or more). Only few drug consumers/abusers (n = 86, mostly cannabis) had been penalized for impaired driving (7%), none had an accident and 69.8% had consumed illicit drugs once a week or more. In the vast majority of these cases other reasons than impaired driving caused authorities action. Laboratory tests were abnormal in 37.3% of alcohol consumers/abusers and in 4.7% of drug consumers/abusers indicating ongoing substance use. Although the increasing use of cannabis and amphetamines is a problem, our data indicate that still alcohol is by far the most dangerous psychotropic substance for traffic safety. Authorities seem to overestimate the risk for road safety associated with illicit drug use.
    Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater 02/2008; 22(2):137-42. · 1.38 Impact Factor
  • Rehabilitation. 01/2008; 47(3):164-171.
  • Egon Michael Haberfellner
    [Show abstract] [Hide abstract]
    ABSTRACT: Das Konzept der komplexen posttraumatischen Belastungsstörung (PTBS) wurde eingeführt, um die psychiatrischen Symptome einiger Patienten zu beschreiben, die nach einer extremen psychischen Traumatisierung auftreten, aber nicht die diagnostischen Kriterien der PTBS erfüllen. Dieses Manuskript präsentiert die DESNOS-Kriterien (disorders of extreme stress not otherwise specified). Argumente pro und contra die Anwendung des Konzeptes der komplexen PTBS werden diskutiert. Der Begriff der komplexen PTBS sollte klar von der Diagnose PTBS nach ICD-10 oder DSM-IV unterschieden werden, aber auch von anderen psychiatrischen Störungsbildern, insbesondere von der Borderline Persönlichkeitsstörung. Das Konzept der komplexen PTSD kann als Arbeitshypothese nützlich sein, kann einen Beitrag zum psychodynamischen Verständnis des Leidens so mancher Patienten leisten und kann auch helfen, spezifische psychotherapeutische Strategien einzusetzen. The concept of complex post-traumatic stress disorder (PTSD) was introduced to describe the psychiatric symptoms of some patients after extreme traumatisation, who do not fulfil the diagnostic criteria of PTSD. This paper presents the DESNOS criteria (disorders of extreme stress not otherwise specified). Arguments pro and contra the use of the concept complex PTSD are discussed. The term complex PTSD should not be mixed up with the diagnostic category PTSD according to ICD-10 or DSM-IV and should be clearly distinguished from other psychiatric disorders, especially from borderline personality disorder. The concept complex PTSD can be useful as a working hypothesis, can contribute to understand a patients suffering from a psychodynamic point of view and can help to establish specific psychotherapeutic strategies.
    Psychiatrie und Psychotherapie 01/2008; 4(3):85-87.
  • Egon Michael Haberfellner
    [Show abstract] [Hide abstract]
    ABSTRACT: Die Schluckangst ist charakterisiert durch Schwierigkeiten beim Schlucken von festen Nahrungsmitteln, Flüssigkeiten oder Tabletten, begleitet durch intensive Angst, eingeschränktes Essverhalten und manchmal auch sekundären Gewichtsverlust. Das Auftreten der Schluckangst wird durch bestehende Angststörungen begünstigt und oft durch Verschlucken ausgelöst. Die Schluckangst wird nicht selten als Essstörung fehldiagnostiziert. Ein typischer Fall, die klinischen Besonderheiten dieser Störung und therapeutische Überlegungen werden vorgestellt. Swallowing phobia is characterized by difficulty swallowing solid food, liquids or pills, accompanied by intense anxiety, restricted eating behaviour and sometimes secondary weight loss. The occurrence of swallowing phobia is facilitated by the presence of pre-existing anxiety disorders and often appears after an episode of choking on food. Swallowing phobia is often misdiagnosed as eating disorder. A typical case of swallowing phobia and the clinical features of the disorder and therapeutic considerations are presented.
    Psychiatrie und Psychotherapie 01/2008; 4(2):66-68.
  • Egon Michael Haberfellner, Sabine Zankl
    Psychotherapie Forum 01/2008; 16(2):92-97.
  • Egon Michael Haberfellner, Hans Rittmannsberger
    Psychiatrische Praxis 06/2006; 33(4):194-6. · 1.64 Impact Factor
  • Egon Michael Haberfellner, Hans Rittmannsberger
    Psychiatrische Praxis 05/2006; 33(4):194-196. · 1.64 Impact Factor
  • E M Haberfellner, H Rittmannsberger
    [Show abstract] [Hide abstract]
    ABSTRACT: Patients can provide appropriate and legally valid consent to treatment with antipsychotics only if they received adequate information on the risk of tardive dyskinesia (TD) and have the capacity to give informed consent. Eighty-seven patients in a psychiatric practice undergoing treatment with antipsychotics were interviewed for their level of information regarding TD and were subsequently provided with additional information on TD as needed. Three months after provision of this information, the interview was repeated. Though 82% of the patients had read the patient information leaflet and 44% had already received previous information, only 17% were found to be informed. The proportion of informed patients increased to 72% at the second interview. Among patients remaining uninformed despite previous information, a statistically significant higher proportion of elderly patients and patients with marked psychopathological impairments was found. Schizophrenic patients' knowledge on TD is low. With appropriate oral information being provided patients' knowledge can be considerably improved in the short run.
    Der Nervenarzt 04/2006; 77(3):333-7. · 0.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The study was intended to evaluate the therapeutic and healthcare services utilized by 116 former long-stay patients after an average of 42.9 months of deinstitutionalization during a follow-up time of (1/2) year and to calculate the costs thus incurred. 116 patients and their caregivers were interviewed during a period of 6 months using the German version of the Client Sociodemographic and Service Receipt Inventory. On average, 3.3 institutions/facilities were contacted per patient, most often by younger patients living in group homes and least often by patients in psychiatric nursing homes. During the 6-month follow-up time costs of euro 14,665 were incurred per patient. Of these costs, 87.2 % were for the residential facilities. The costs of outpatient care accounted for 41.4 % of the costs that would have been incurred for inpatient care in a psychiatric hospital. Deinstitutionalization of psychiatric long-stay patients in Upper Austria provided for considerable reductions in costs while maintaining a high quality of care.
    Psychiatrische Praxis 04/2006; 33(2):74-80. · 1.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to assess the needs for care of 116 former long-stay patients during the first 42.9 months after discharge. Patients and mental health professionals rated needs using the "Berliner Bedürfnisinventar" (Berlin Needs for Care Inventory). Out of a total of 16 needs areas, patients reported a mean number of 7.6 needs, therapists reported 10 needs. Patients with lower global functioning scores showed a significantly lower number of needs, while patients living in psychiatric nursing homes and patients with learning disabilities had a significantly higher number of needs. In most areas, agreement between patients' and therapists' assessment was good to moderate. In most areas the rate of unmet versus total needs was above 90 %. Patients received help almost exclusively from institutions or mental health services. The care needs of discharged patients were generally met and placement in institutions was considered appropriate.
    Psychiatrische Praxis 02/2006; 33(1):23-9. · 1.64 Impact Factor
  • Psychiatrische Praxis - PSYCHIAT PRAX. 01/2006; 33(02):74-80.
  • Psychiatrische Praxis 01/2006; 33(01):23-29. · 1.64 Impact Factor
  • E. M. Haberfellner, H. Rittmannsberger
    [Show abstract] [Hide abstract]
    ABSTRACT: ZusammenfassungHintergrund Patienten können nur rechtskräftig der Behandlung mit Antipsychotika zustimmen, wenn sie einwilligungsfähig und über das Risiko tardiver Dyskinesien (TD) informiert sind.Methode Siebenundachtzig Patienten einer psychiatrischen Praxis, die mit Antipsychotika behandelt wurden, wurden über ihren Wissensstand betreffend TD befragt und — wenn erforderlich — anschließend über TD informiert. Drei Monate nach dem Informationsgespräch wurde die Befragung wiederholt.Ergebnisse Obwohl 82% der Patienten die Gebrauchsinformation gelesen hatten und 44% bereits vorher informiert worden waren, hatten nur 17% beim Erstgespräch ausreichende Kenntnisse über TD. Der Anteil der informierten Patienten stieg auf 72% beim Zweitinterview an. Unter den Patienten, die trotz Aufklärung uninformiert blieben, fanden sich statistisch signifikant mehr Ältere und Patienten mit mehr psychopathologischen Beeinträchtigungen.Schlussfolgerungen Das Wissen schizophrener Patienten über TD ist gering. Kurzfristig konnte durch ein Informationsgespräch der Wissensstand der Patienten wesentlich erhöht werden.
    Der Nervenarzt 01/2006; 77(3):333-337. · 0.80 Impact Factor
  • Egon Michael Haberfellner, Hans Rittmannsberger
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to assess the prevalence of weight gain during long-term treatment with olanzapine under routine conditions. Weight changes in a sample of 27 outpatients with schizophrenic or schizoaffective disorder were assessed over a mean duration of treatment of 22 months (6-42 months). Treatment with olanzapine was started anew or switched from a conventional antipsychotic drug. Eighteen (66.7%) patients gained more than 7% of their initial body weight. Mean weight gain was 9.2 kg over the study period for the first year 7.7 kg, and only 1.7 kg in the second year. Due to some patients losing weight in the second year, the latter finding obscures the fact that more than 50% of patients gained considerable weight also during the second year (4.8 kg). Weight gain per month was significantly higher in patients with lower body mass index, yet the highest weight gain was found in the most obese patient. Weight gain under olanzapine is a serious concern, and should be monitored closely and countered by active measures.
    International Clinical Psychopharmacology 08/2004; 19(4):251-3. · 2.71 Impact Factor
  • E M Haberfellner, H Rittmannsberger
    [Show abstract] [Hide abstract]
    ABSTRACT: Orgasm delay is a common side effect of SSRIs,causing negative influence on patients' compliance and quality of life. A possible strategy for the management of SSRI-induced orgasm delay is waiting for tolerance to develop. The authors studied the natural course of SSRI-induced orgasm delay over a period of 6 months. One hundred eight patients having been started on SSRIs were included in an open, naturalistic study. Sexual dysfunction was assessed at monthly intervals using a structured interview. Twenty-six patients developed clinically relevant SSRI-induced orgasm delay. Eight patients (30.8%) reported complete remission of sexual dysfunction, while four patients (15.4%) noted a marked improvement. Four patients (15.4%) continued to describe severe orgasm delay at the end of the observation period. High severity of orgasm delay significantly correlated with lack of remission. A significant proportion of patients, especially those with mild to moderate orgasm delay, develop tolerance within 6 months.
    Pharmacopsychiatry 06/2004; 37(3):127-30. · 2.11 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In Upper Austria, a total of 409 long-stay patients were discharged to various residential facilities between 1995 and 2000. This paper describes psychopathology and sociodemographic characteristics. A random sample of 116 former long-stay patients were followed for an average 42.9 months after discharge. Patients had spent an average 19.3 years in psychiatric wards. 47 patients (40.5 %) were placed in nursing homes, 16 patients (13.8 %) in old-age homes, 32 patients (27.6 %) in other institutions and only 15 patients (12.9 %) in group homes, and 6 patients (5.2 %) with families. ICD-10 diagnosis was schizophrenia in 56 patients (48.3 %) and mental retardation in 33 patients (28.4 %). Level of social and functional disabilities was high. Most long-stay patients were able to live outside psychiatric hospitals, but institutional care still plays an essential role.
    Psychiatrische Praxis 06/2004; 31(4):192-7. · 1.64 Impact Factor